Patrick Brenske has gained his economical know-how through his studies at the American University, Washington D.C., and at the Frankfurt School of Finance, where he received his master degree. He received his experience in the pharmaceutical industry through his position as director of purchasing and sales at HAEMATO PHARM AG, for which he is responsible since 2007.
Mr. Brenske was appointed CEO of the MPH Mittelständische Pharma Holding AG on January 23rd 2009 and is responsible for the entire operational business.

Dr. Christian Pahl was appointed member of the management board of the MPH Mittelständische Pharma Holding on May 17th 2010. He is acting in the CFO role. After completing his economics studies and his doctorate in finance, Dr. Pahl started his professional career with the audit firm Arthur Andersen, Hamburg, Germany. Before his entry in MPH, Dr. Pahl held the position of CFO in several medium-sized  companies dealing in semiconductor development, electronic household appliances and telecommunication.